Her2treatment - her2treatment.com : HER2+ Breast Cancer Treatment with Herceptin® (trastuzumab)

1.67 Rating by ClearWebStats

her2treatment.com is 1 decade 9 years 6 months old. This website has a #6,482,675 rank in global traffic. It has a .com as an domain extension. This domain is estimated value of $ 8.95 and has a daily earning of $ 0.15. While no active threats were reported recently by users, her2treatment.com is SAFE to browse.

Updated 9 years 11 months ago

Get Custom Widget

Traffic Report of Her2treatment

Daily Unique Visitors:	74
Daily Pageviews:	148

Estimated Valuation

Income Per Day:	$ 0.15
Estimated Worth:	$ 8.95

Search Engine Indexes

Google Indexed Pages:	Not Applicable
Yahoo Indexed Pages:	Not Applicable
Bing Indexed Pages:	2

Search Engine Backlinks

Google Backlinks:	Not Applicable
Bing Backlinks:	Not Applicable
Alexa BackLinks:	2

Safety Information

Google Safe Browsing:	No Risk Issues
Siteadvisor Rating:	Not Applicable
WOT Trustworthiness:	Not Applicable
WOT Privacy:	Not Applicable
WOT Child Safety:	Not Applicable

Website Ranks & Scores

Google Pagerank:	Not Applicable
Alexa Rank:	6,482,675
Domain Authority:	Not Applicable

Google Pagerank

PR 0 out of 10

PageSpeed Score

Siteadvisor Rating

Not Applicable

Where is her2treatment.com server located?

Hosted IP Address:

72.34.128.116

View other site hosted with her2treatment.com

Hosted Country:

Location Latitude:

37.7749

Location Longitude:

-122.419

Social Engagement

Facebook Shares:	Not Applicable
Facebook Likes:	Not Applicable
Facebook Comments:	Not Applicable
Twitter Count (Tweets):	Not Applicable
Linkedin Shares:	Not Applicable
Delicious Shares:	Not Applicable

Page Resources Breakdown

Homepage Links Analysis

View her2treatment.com homepage link analysis

Page Title of Her2treatment

HER2+ Breast Cancer Treatment with Herceptin® (trastuzumab)

Meta Description of Her2treatment

Find information about Herceptin® (trastuzumab), a targeted therapy for HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer. Who is Herceptin for? Adjuvant Breast Cancer: Herceptin is approved for the treatment of early-stage breast cancer that is Human Epidermal growth factor Receptor 2-positive (HER2+) and has spread into the lymph nodes, or is HER2+ and has not spread into the lymph nodes. If it has not spread into the lymph nodes, the cancer needs to be estrogen receptor/progesterone receptor (ER/PR)-negative or have one high risk feature.* Herceptin can be used in several different ways: As part of a treatment course including the chemotherapy drugs Adriamycin® (doxorubicin), Cytoxan® (cyclophosphamide), and either Taxol® (paclitaxel) or Taxotere® (docetaxel). This treatment course is known as 'AC-TH'. With the chemotherapy drugs Taxotere and Paraplatin® (carboplatin). This treatment course is known as 'TCH'. Alone after treatment with multiple other therapies, including an anthracycline (Adriamycin)-based therapy (a type of chemotherapy) *High risk is defined as ER/PR-positive with one of the following features: tumor size >2 cm, age

Meta Tags of Her2treatment

herceptin, trastuzumab, breast cancer treatment, her2, her2 positive breast cancer, her2 positive gastric cancer

Website Inpage Analysis

H1 Headings:	Not Applicable	H2 Headings:	3
H3 Headings:	14	H4 Headings:	Not Applicable
H5 Headings:	Not Applicable	H6 Headings:	Not Applicable
Total IFRAMEs:	1	Total Images:	9
Google Adsense:	Not Applicable	Google Analytics:	UA-6741107-1

Websites Hosted on Same IP (i.e. 72.34.128.116)

Advanced Skin Cancer Stories - Faces of Skin Cancer

- facesofskincancer.org

Faces of Skin Cancer is a space for people affected by advanced skin cancer to share their stories.

Not Applicable her2treatment.com website value

$ 8.95

XENICAL.com Home

- xenical.com

Xenical.com provides the information and tools needed to talk to your doctor about developing a weight loss program and reaching your health goals.

1,174,714

$ 720.00

Retina Eye Exam for Preventing Vision Loss from Diabetes | Diabetes Eye Check

- diabeteseyecheck.org

Learn how diabetes can lead to vision loss and what yearly retina eye exams can do to help.

5,057,300

$ 240.00

Welcome to: Weightloss.com

- weightloss.com

1,581,839

$ 480.00

My Transplant Life

- mytransplantlife.com

Not Applicable her2treatment.com website value

$ 8.95

HTTP Header Analysis

Http-Version: 1.1
Status-Code: 200
Status: 200 OK
Date: Sat, 14 Jun 2014 15:21:32 GMT
X-Powered-By: Servlet 2.5; JBoss-5.0/JBossWeb-2.1
Content-Language: en-US, en
Connection: close
Content-Type: text/html;charset=UTF-8

Domain Information for her2treatment.com

Domain Registrar:	CSC CORPORATE DOMAINS, INC.
Registration Date:	2004-11-09 1 decade 9 years 6 months ago
Last Modified:	2014-02-25 1 decade 2 months 2 weeks ago
Expiration Date:	2014-11-09 9 years 6 months 1 week ago

Domain Nameserver Information

Host	IP Address	Country
dnadns2e.gene.com	72.34.128.76	United States
dnadns3e.gene.com	72.34.133.50	United States
dnadns4e.gene.com	72.34.128.50	United States

DNS Record Analysis

Host	Type	TTL	Extra
her2treatment.com	A	3584	IP:72.34.128.116
her2treatment.com	NS	3600	Target:dnadns2e.gene.com
her2treatment.com	NS	3600	Target:dnadns4e.gene.com
her2treatment.com	NS	3600	Target:dnadns3e.gene.com
her2treatment.com	SOA	3600	MNAME:bc-dns-ext-mstr.gene.com RNAME:postmaster.no.email.please Serial:404592124 Refresh:3600 Retry:600 Expire:2592000

Similarly Ranked Websites to Her2treatment

Virginia Department of Motor Vehicles

- dmvnow.com

Welcome to the official site of the Virginia Department of Motor Vehicles, with quick access to driver and vehicle online transactions and information.